Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects

NCT02127034 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Pharmacokinetics
Drug-Drug Interaction (DDI)

Interventions

DRUG: Mirabegron
DRUG: Solifenacin
DRUG: Digoxin

Sponsor

Astellas Pharma Europe B.V.